Ascendis Pharma
ASND
ASND
96 hedge funds and large institutions have $2.85B invested in Ascendis Pharma in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 40 increasing their positions, 29 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
96
Holders Change
-6
Holders Change %
-5.88%
% of All Funds
2.2%
Holding in Top 10
13
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+8.33%
% of All Funds
0.3%
New
9
Increased
40
Reduced
29
Closed
15
Calls
$22.6M
Puts
$5.23M
Net Calls
+$17.4M
Net Calls Change
-$9.22M
Top Buyers
Top Sellers
| 1 |
EC
1
EcoR1 Capital
San Francisco,
California
|
$77M |
| 2 |
2
Millennium Management
New York
|
$15.3M |
| 3 |
O
3
OrbiMed
New York
|
$294M |
| 4 |
ACP
4
Acuta Capital Partners
Redwood City,
California
|
$5.07M |
| 5 |
DM
5
Deerfield Management
New York
|
$22.7M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
SG Americas Securities
New York
| – | -$762K | -11,461 | Closed |
|
|
VIA
102
Vident Investment Advisory
Alpharetta,
Georgia
| – | -$518K | -7,785 | Closed |
|
103
Squarepoint
New York
| – | -$286K | -4,300 | Closed |
|
|
KA
104
Kovack Advisors
Ft. Lauderdale,
Florida
| – | -$228K | -3,430 | Closed |
|
105
Simplex Trading
Chicago,
Illinois
| – | -$190K | -2,864 | Closed |
|
|
QT
106
Quantbot Technologies
New York
| – | -$119K | -1,789 | Closed |
|
107
CIBC Private Wealth Group
Atlanta,
Georgia
| – | -$67K | -1,000 | Closed |
|
|
CG
108
Cutler Group
San Francisco,
California
| – | -$53K | -800 | Closed |
|
|
TRCT
109
Tower Research Capital (TRC)
New York
| – | -$8K | -115 | Closed |
|
110
Group One Trading
Chicago,
Illinois
| – | -$7K | -98 | Closed |
|